MTB
UTHR icon

Mizuho Trust & Banking’s United Therapeutics UTHR Stock Holding History

Mizuho Trust & Banking’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-66,738
Closed -$7.88M – 627
2016
Q3 		$7.88M Sell
66,738
-765
-1% -$91.9K 0.02% 581
2016
Q2 		$7.15M Sell
67,503
-2,416
-3% -$269K 0.02% 593
2016
Q1 		$7.79M Buy
69,919
+1,436
+2% +$182K 0.02% 576
2015
Q4 		$10.9M Buy
68,483
+2,962
+5% +$431K 0.04% 500
2015
Q3 		$8.6M Buy
65,521
+876
+1% +$141K 0.03% 555
2015
Q2 		$11.2M Buy
+64,645
New +$11.6M 0.04% 513

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Mizuho Trust & Banking's UTHR Position: Q4 2016 in Review

Mizuho Trust & Banking sold out of United Therapeutics (UTHR) in Q4 2016, closing a stake of 66,738 shares — an estimated $7.88M sold.

Mizuho Trust & Banking first reported a position in UTHR in Q2 2015 and held it in 6 quarters. The position peaked at $11.2M in Q2 2015. 406 funds tracked by Wall St. Rank hold UTHR as of Q4 2016.

  • Mizuho Trust & Banking reported no remaining United Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Mizuho Trust & Banking sold 66,738 United Therapeutics shares in Q4 2016, an estimated $7.88M.
  • Mizuho Trust & Banking first reported a position in United Therapeutics in Q2 2015 and held it in 6 quarters.
  • Mizuho Trust & Banking's United Therapeutics position peaked at $11.2M in Q2 2015.
  • 406 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2016.

Based on Mizuho Trust & Banking's 13F filing for Q4 2016, filed 14 Feb 2017.